CAS: 473921-12-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile REF: IN-DA00DB6KCAS: 473921-12-9 | 98% | 106,00 €~610,00 € | Vie 07 Feb 25 |
 | Lersivirine REF: TM-T7700CAS: 473921-12-9 | 98.01% | 47,00 €~599,00 € | Vie 14 Feb 25 |
 | Lersivirine REF: 3D-FL65058CAS: 473921-12-9 | Min. 95% | 473,00 €~1.864,00 € | Mar 18 Feb 25 |
![3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile](https://static.cymitquimica.com/products/IN/thumb/DA00DB6K.jpg)
3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile
CAS:473921-12-9
Fórmula:
C17H18N4O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
310.3504
Ref: IN-DA00DB6K
| 25mg | 161,00 € | ||
| 50mg | 271,00 € |
Entrega estimada en Estados Unidos, el Viernes 7 de Febrero de 2025
Lersivirine
CAS:473921-12-9
Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV …
Fórmula:
C17H18N4O2
Pureza:
98.01%
Forma y color:
Solid
Peso molecular:
310.35
Ref: TM-T7700
| 1mg | 47,00 € | ||
| 5mg | 89,00 € | ||
| 10mg | 143,00 € | ||
| 25mg | 263,00 € | ||
| 50mg | 414,00 € | ||
| 100mg | 599,00 € | ||
| 1mL*10mM (DMSO) | 95,00 € |
Entrega estimada en Estados Unidos, el Viernes 14 de Febrero de 2025
Lersivirine
CAS:473921-12-9
Anti-viral; non-nucleoside reverse transcriptase inhibitor
Fórmula:
C17H18N4O2
Pureza:
Min. 95%
Forma y color:
Solid
Peso molecular:
310.14298
Ref: 3D-FL65058
| 5mg | 473,00 € | ||
| 10mg | 761,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
